Trial Profile
Effect of ezetimibe on PCSK9 concentrations in patients with type 2 diabetes and hypercholesterolemia
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin; Pitavastatin; Rosuvastatin
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 10 Sep 2015 New trial record